REGENERON PHARMACEUTICALS, INC. Total Operating Expenses 2008-2026 | REGN
What is total operating expenses?
Total operating expenses include all costs related to running the core business, including cost of goods sold, R&D, and SG&A.
What is REGENERON PHARMACEUTICALS, INC.'s current total operating expenses?
REGENERON PHARMACEUTICALS, INC. (REGN) annual total operating expenses for 2025 was $10.77B, a 5.42% increase from 2024. REGENERON PHARMACEUTICALS, INC. total operating expenses for the quarter ending March 31, 2026 was $2.96B.
What was REGENERON PHARMACEUTICALS, INC.'s total operating expenses in 2024?
REGENERON PHARMACEUTICALS, INC. annual total operating expenses for 2024 was $10.21B, a 12.58% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s total operating expenses in 2023?
REGENERON PHARMACEUTICALS, INC. annual total operating expenses for 2023 was $9.07B, a 22.01% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year total operating expenses CAGR?
REGENERON PHARMACEUTICALS, INC. total operating expenses grew at a compound annual growth rate (CAGR) of 16.95% from FY2020 to FY2025, going from $4.92B to $10.77B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $10.77B | +5.4% | 10-K |
| FY2024 | $10.21B | +12.6% | 10-K |
| FY2023 | $9.07B | +22.0% | 10-K |
| FY2022 | $7.43B | +4.3% | 10-K |
| FY2021 | $7.12B | +44.8% | 10-K |
| FY2020 | $4.92B | +13.2% | 10-K |
| FY2019 | $4.35B | +66.5% | 10-K |
| FY2018 | $2.61B | -31.2% | 10-K |
| FY2017 | $3.79B | +7.4% | 10-K |
| FY2016 | $3.53B | +23.8% | 10-K |
| FY2015 | $2.85B | +42.9% | 10-K |
| FY2014 | $2.00B | +46.6% | 10-K |
| FY2013 | $1.36B | +47.9% | 10-K |
| FY2012 | $920.8M | +41.4% | 10-K |
| FY2011 | $651.0M | +17.0% | 10-K |
| FY2010 | $556.5M | +22.8% | 10-K |
| FY2009 | $453.4M | +39.6% | 10-K |
| FY2008 | $324.7M | - | 10-K |